Malignant bowel obstruction ( MBO )

Criteria for Malignant bowel obstruction ( MBO ) were defined in 2007 at the International Conference on MBO as Clinical evidence of bowel obstruction Bowel obstruction beyond the ligament of Treitz and Intraabdominal primary cancer with incurable disease or Non-intraabdominal primary cancer with clear intraperitoneal disease

Recognised complication of advanced pelvic or abdominal malignancy Global prevalence is reported to range from 3 % to 15 % of cancer patients Its a challenging problem and can be seen in up to 51 % of patients with colorectal , ovarian , pancreatic and gastric cancers Most frequently reported with○ colon ( 25 % to 40 % )○ ovarian cancer ( 16 % to 29 % )- dominant cause in women○ stomach ( 6 % to 19 % )○ pancreas ( 6 % to 13 % )○ bladder and endometriumpercentages quoted may vary slightly between studies Primary cancer of extraabdominal origin leading to MBO are due to peritoneal infiltration of breast cancer and melanoma Seen more commonly in women ( with advanced gynaecological cancers ) MBO can be the presenting feature of patients with advanced or terminal disease

Obstruction can be at any level /more than 1 level Small bowel obstruction is 4...